Curaleaf Holdings (CURLF) Gains from Investment Securities (2020 - 2023)
Curaleaf Holdings (CURLF) posted quarterly Gains from Investment Securities of $800000.0 for Q3 2023, up 102.97% quarter-over-quarter from -$27.0 million in Q4 2020.
Curaleaf Holdings (CURLF) Gains from Investment Securities (2020 - 2023) Analysis & Trends
Curaleaf Holdings' Gains from Investment Securities history runs 2 years deep, the most recent figure standing at $800000.0 for Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Curaleaf Holdings | 2.51 Bn | 2.42 Bn | 169.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 800,000.00 |
| Sep 30, 2023 | 800,000.00 |
| Dec 31, 2020 | -26.96 Mn |
| Dec 31, 2020 | -26.96 Mn |